Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian C Smith

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Journal of Neuromuscular Diseases|February 20, 2025
Plasma-derived protein and imaging biomarkers distinguish disease severity in oculopharyngeal muscular dystrophyIan C Smith, Marcos L Sampaio, Gerd Melkus, et al.
Orphanet Journal of Rare Diseases|August 7, 2025
Assessing the socio-economic burden of inherited and inflammatory neuromuscular diseases (BIND study): a study protocolIan C Smith, Yasmin Abusetah, Homira Osman, et al.
Breast Cancer Research and Treatment|August 10, 2006
Monitoring primary breast cancer throughout chemotherapy using FDG-PETGarry M McDermott, Andrew Welch, Roger T Staff, et al.
Journal of the Neurological Sciences|January 7, 2024
Congenital tremor and myopathy secondary to novel MYBPC1 variantHeather Leduc-Pessah, Ian C Smith, Kristin D Kernohan, et al.
Disease Models & Mechanisms|June 3, 2015
Phospholamban overexpression in mice causes a centronuclear myopathy-like phenotypeVal A Fajardo, Eric Bombardier, Elliott McMillan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxelIan C Smith, Steven D Heys, Andrew W Hutcheon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2017
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine TherapyGeorge W Sledge, Masakazu Toi, Patrick Neven, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2017
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast CancerMatthew P Goetz, Masakazu Toi, Mario Campone, et al.
Neurology. Genetics|April 20, 2023
Novel Homozygous Variant in <i>COQ7</i> in Siblings With Hereditary Motor NeuropathyIan C Smith, Chantal A Pileggi, Ying Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2020
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)Stephen R D Johnston, Nadia Harbeck, Roberto Hegg, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Journal of Neuromuscular Diseases|February 20, 2025
Plasma-derived protein and imaging biomarkers distinguish disease severity in oculopharyngeal muscular dystrophyIan C Smith, Marcos L Sampaio, Gerd Melkus, et al.
Orphanet Journal of Rare Diseases|August 7, 2025
Assessing the socio-economic burden of inherited and inflammatory neuromuscular diseases (BIND study): a study protocolIan C Smith, Yasmin Abusetah, Homira Osman, et al.
Breast Cancer Research and Treatment|August 10, 2006
Monitoring primary breast cancer throughout chemotherapy using FDG-PETGarry M McDermott, Andrew Welch, Roger T Staff, et al.
Journal of the Neurological Sciences|January 7, 2024
Congenital tremor and myopathy secondary to novel MYBPC1 variantHeather Leduc-Pessah, Ian C Smith, Kristin D Kernohan, et al.
Disease Models & Mechanisms|June 3, 2015
Phospholamban overexpression in mice causes a centronuclear myopathy-like phenotypeVal A Fajardo, Eric Bombardier, Elliott McMillan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxelIan C Smith, Steven D Heys, Andrew W Hutcheon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2017
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine TherapyGeorge W Sledge, Masakazu Toi, Patrick Neven, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2017
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast CancerMatthew P Goetz, Masakazu Toi, Mario Campone, et al.
Neurology. Genetics|April 20, 2023
Novel Homozygous Variant in <i>COQ7</i> in Siblings With Hereditary Motor NeuropathyIan C Smith, Chantal A Pileggi, Ying Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2020
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)Stephen R D Johnston, Nadia Harbeck, Roberto Hegg, et al.
Pageof 9